“This monopoly gives patent holders total control over patented genetic materials for any use whatsoever whether for basic research, a diagnostic test, as a test for the efficacy of a drug or the production of therapies.”
Several examples are cited in the article to suggest how against the public interest these patents can be.
In one case cited, "Patient groups filed suit in 2000, contending misappropriation of trade secrets by using their children's DNA without consent to obtain a patent. It took until 2003 for the parties to reach a confidential settlement; it allows certain laboratories to continue collecting royalties but lets institutions, doctors and scientists use the patented gene sequences without paying."
Dismal story. Read the rest.